CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). (March 2022) - Horne, Ashley; Ali, Aaisha; Brown, Sarah; Butterworth, Karl; Chalmers, Anthony; Clipson, Alexandra; Collinson, Fiona; Dive, Caroline; Faivre-Finn, Corinne; Forster, Martin; Franks, Kevin; Gilbert, Alexandra; et al.